Education
About Us
Working with TipRanks
Follow Us
Medirom Healthcare Technologies, Inc. (MRM)
:MRM
RESEARCH TOOLSreports
Total Valuation
MEDIROM Healthcare Technologies has a market cap or net worth of $5.95M. The enterprise value is $29.89M.
Market Cap$5.95M
Enterprise Value$29.89M
Share Statistics
MEDIROM Healthcare Technologies has 7,901,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,901,950
Owned by Insiders―
Owned by Institutions0.74%
Financial Efficiency
MEDIROM Healthcare Technologies’s return on equity (ROE) is 0.55 and return on invested capital (ROIC) is -47.99%.
Return on Equity (ROE)0.55
Return on Assets (ROA)0.02
Return on Invested Capital (ROIC)-47.99%
Return on Capital Employed (ROCE)-0.12
Revenue Per Employee15.88M
Profits Per Employee267.56K
Employee Count430
Asset Turnover1.00
Inventory Turnover37.57
Valuation Ratios
The current PE Ratio of MEDIROM Healthcare Technologies is 36.20. MEDIROM Healthcare Technologies’s PEG ratio is -1.34.
PE Ratio36.20
PS Ratio0.00
PB Ratio19.75
Price to Fair Value19.75
Price to FCF-5.43
Price to Operating Cash Flow-6.59
PEG Ratio-1.34
Income Statement
In the last 12 months, MEDIROM Healthcare Technologies had revenue of 6.83B and earned 115.05M in profits. Earnings per share was 22.27.
Revenue6.83B
Gross Profit1.57B
Operating Income-391.58M
Pretax Income20.62M
Net Income115.05M
EBITDA310.08M
Earnings Per Share (EPS)22.27
Cash Flow
In the last 12 months, operating cash flow was -807.42M and capital expenditures -98.29M, giving a free cash flow of -905.71M billion.
Operating Cash Flow-807.42M
Free Cash Flow-905.71M
Free Cash Flow per Share-114.62
Dividends & Yields
MEDIROM Healthcare Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change-85.58%
50-Day Moving Average0.67
200-Day Moving Average2.05
Relative Strength Index (RSI)51.96
Average Volume (3m)2.66M
Important Dates
MEDIROM Healthcare Technologies upcoming earnings date is Nov 10, 2025, TBA Not Confirmed.
Last Earnings DateFeb 18, 2025
Next Earnings DateNov 10, 2025
Ex-Dividend Date―
Financial Position
MEDIROM Healthcare Technologies as a current ratio of 0.49, with Debt / Equity ratio of -982.55%
Current Ratio0.49
Quick Ratio0.45
Debt to Market Cap0.37
Net Debt to EBITDA11.43
Interest Coverage Ratio-10.62
Taxes
In the past 12 months, MEDIROM Healthcare Technologies has paid -94.43M in taxes.
Income Tax-94.43M
Effective Tax Rate-4.58
Enterprise Valuation
MEDIROM Healthcare Technologies EV to EBITDA ratio is 24.86, with an EV/FCF ratio of -10.04.
EV to Sales1.13
EV to EBITDA24.86
EV to Free Cash Flow-10.04
EV to Operating Cash Flow-12.20
Balance Sheet
MEDIROM Healthcare Technologies has $144.65M in cash and marketable securities with ¥2.46B in debt, giving a net cash position of $3.42B billion.
Cash & Marketable Securities$144.65M
Total Debt¥2.46B
Net Cash$3.42B
Net Cash Per Share$433.31
Tangible Book Value Per Share-$230.23
Margins
Gross margin is 20.77%, with operating margin of -5.73%, and net profit margin of 1.68%.
Gross Margin20.77%
Operating Margin-5.73%
Pretax Margin0.30%
Net Profit Margin1.68%
EBITDA Margin4.54%
EBIT Margin0.84%
Analyst Forecast
The average price target for MEDIROM Healthcare Technologies is $5.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.00
Price Target Upside566.67% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast-7.60%
EPS Growth Forecast-118.80%